4King S. Forbes K, Hanks GW, et al. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairmen [J] . Palliat Med, 2011, 255): 525-552.
5St Germaine CG, Bopaty P, Boyer L, et al. Genetic polymorphsms and the cardiovascular risk of monsteroidalanti inflammatory drugs [J] . Cardiology, 2010, 13: 1740-1745.
